Senators Tie Medicare Oral Drug Payment to Ending Markup on Infused Drugs
Bass & Howes Bought By DDB Seattle
Surgical Oncologists Honor HHS Secretary
Medical Adfances Not Driven Entirely By Science, Author Tells Journalists
Evidence Too Weak to Link Agent Orange, Cancer, IOM Says
IARC Says Evidence Supports Mammography Screening For 50-69, Limited Evidence For 40-49
Funding Opportunities.
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest
- As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - In the Headlines: MD Anderson’s Pisters on doing “something gigantic for pediatric cancer”
- Scaling excellence: How City of Hope is transforming cancer care delivery